ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.82
-0.49%
US Tech 100
18,922.80
0.07%
S&P 500
5,572.07
-0.76%
US Dollar vs CAD
1.44408
0.05%
Bitcoin
82,351.36
-0.60%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Fulcrum Therapeutics Inc (FULC) Share Price

Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc (FULC)

NASDAQ
2.96
-0.01
(-0.34%)
Closed March 11 3:00PM
Delayed by 15 minutes
2.99
0.03
(1.01%)
After Hours: 6:22PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.99
Bid
2.82
Ask
3.03
Volume
781,560
2.815 Day's Range 3.02
2.86 52 Week Range 12.40
Market Cap
161.398M
Previous Close
2.97
Open
2.98
Last Trade
1
@
2.9899
Last Trade Time
Financial Volume
US$ 2,267,304
VWAP
2.901
Average Volume (3m)
654,575
Shares Outstanding
53,979,306
Dividend Yield
-
PE Ratio
-1.64
Earnings Per Share (EPS)
-1.8
Revenue
2.81M
Net Profit
-97.34M

About Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treat... Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.fulcrumtx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Fulcrum Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FULC. The last closing price for Fulcrum Therapeutics was US$2.97. Over the last year, Fulcrum Therapeutics shares have traded in a share price range of US$ 2.86 to US$ 12.40.

Fulcrum Therapeutics currently has 53,979,306 shares outstanding. The market capitalization of Fulcrum Therapeutics is US$160.32 million. Fulcrum Therapeutics has a price to earnings ratio (PE ratio) of -1.64.

Ask ADVFN Intelligence (AI)

FULC Latest News

More News

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 25 2025
FULC (-0.34%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
February 25 2025
FULC (-0.34%)

Form 8-K - Current report
Edgar (US Regulatory)
February 25 2025
FULC (-0.34%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 28 2025
FULC (-0.34%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 28 2025
FULC (-0.34%)

Form 8-K - Current report
Edgar (US Regulatory)
December 23 2024
FULC (-0.34%)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
December 06 2024
FULC (-0.34%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 13 2024
FULC (-0.34%)

Form 8-K - Current report
Edgar (US Regulatory)
November 13 2024
FULC (-0.34%)

Form 8-K - Current report
Edgar (US Regulatory)
November 12 2024
FULC (-0.34%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1199-3.855429435033.10993.412.93290273.17700922CS
4-0.57-16.01123595513.563.942.93997413.48602697CS
12-1.51-33.55555555564.55.17132.96545754.18070357CS
26-5.38-64.27718040628.378.872.8611933933.68408987CS
52-7.98-72.743846855110.9712.42.869580505.38258438CS
156-13.26-81.616.2524.792.259302436.1954934CS
260-9.89-76.785714285712.8833.09752.2580572410.04282342CS

FULC - Frequently Asked Questions (FAQ)

What is the current Fulcrum Therapeutics share price?
The current share price of Fulcrum Therapeutics is US$ 2.99
How many Fulcrum Therapeutics shares are in issue?
Fulcrum Therapeutics has 53,979,306 shares in issue
What is the market cap of Fulcrum Therapeutics?
The market capitalisation of Fulcrum Therapeutics is USD 160.32M
What is the 1 year trading range for Fulcrum Therapeutics share price?
Fulcrum Therapeutics has traded in the range of US$ 2.86 to US$ 12.40 during the past year
What is the PE ratio of Fulcrum Therapeutics?
The price to earnings ratio of Fulcrum Therapeutics is -1.64
What is the cash to sales ratio of Fulcrum Therapeutics?
The cash to sales ratio of Fulcrum Therapeutics is 56.73
What is the reporting currency for Fulcrum Therapeutics?
Fulcrum Therapeutics reports financial results in USD
What is the latest annual turnover for Fulcrum Therapeutics?
The latest annual turnover of Fulcrum Therapeutics is USD 2.81M
What is the latest annual profit for Fulcrum Therapeutics?
The latest annual profit of Fulcrum Therapeutics is USD -97.34M
What is the registered address of Fulcrum Therapeutics?
The registered address for Fulcrum Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Fulcrum Therapeutics website address?
The website address for Fulcrum Therapeutics is www.fulcrumtx.com
Which industry sector does Fulcrum Therapeutics operate in?
Fulcrum Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RAYRaytech Holding Ltd
US$ 1.69
(94.25%)
104.03M
TSVT2seventy bio Inc
US$ 4.945
(76.61%)
31.49M
HSAIHesai Group
US$ 24.10
(50.53%)
26.82M
SPHLSpringview Holdings Ltd
US$ 6.00
(47.06%)
1.63M
SYRSSyros Pharmaceuticals Inc
US$ 0.1334
(45.63%)
695.66M
WCTWellchange Holdings Company Limited
US$ 0.68417
(-72.74%)
37.72M
ARVNArvinas Inc
US$ 8.29
(-52.79%)
19.03M
LZMHLZ Technology Holdings Ltd
US$ 8.011
(-48.84%)
685.95k
HTCOHigh Trend International Group
US$ 1.41
(-33.80%)
188.46k
SPGCSacks Parente Golf Inc
US$ 0.1061
(-33.73%)
36.38M
SYRSSyros Pharmaceuticals Inc
US$ 0.1334
(45.63%)
695.66M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0402
(20.00%)
411.84M
NVDANVIDIA Corporation
US$ 108.76
(1.66%)
354.43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.93
(7.45%)
304.67M
CUTRCutera Inc
US$ 0.1079
(-16.03%)
218.46M

Discussion

View Full Feed
Monroe1 Monroe1 57 seconds ago
Super happy camper here! 5,000 tons of top layer material. Deeper will cost a tad more but grade usually increases with depth. Where's my damn pick and single jack? Anyone expecting an update on next shipment to the mill?
NBRI
tw0122 tw0122 1 minute ago
Trump collects $50 million donations from crypto executives
BTCUSD
bas2020 bas2020 1 minute ago
Another boilerplate FUDpost... lame. 👿☠️
NWBO
bas2020 bas2020 2 minutes ago
FUD
NWBO
janice shell janice shell 2 minutes ago
They do say they have nine lives. Now his will last longer. But try to make him a housecoat. They can get into too much trouble wandering around outside, especially where there's traffic. And large dogs.
ada ada 2 minutes ago
Thanks Rick. I won't be able to post like I used to. I have a real job now, lol.
Glad to see all the regulars again like yourself. Hope you guys loaded when it was under $1
FNMA
fuagf fuagf 3 minutes ago
A relatively new progressive face would be good, and
https://www.theguardian.com/us-news/2025/mar/11/katie-porter-democrat-california-governor-race ,
with raps from you and our arizona1 rep, Porter must be one to vote for.
Cambreau Cambreau 3 minutes ago
" I hope a group will run this ". We all hope so too. Those Dec- Jan. frustrating tweets have run this to no bid !
NAFS
29YEARINVESTOR 29YEARINVESTOR 4 minutes ago
I agree I have made many 41% to 200% flips with Igpk.
Glad you like it!j
I would like to see another one of those 533% runs like it has had in the past.
Good Luck and Happy Trading!
IGPK
kazzy kazzy 4 minutes ago
Rigzone has an informative article on the latest approval. No mention of TGLO though.

...The under-construction project now has until June 1, 2029, to dispatch its first non-FTA cargo of LNG.

Delfin LNG is authorized to ship the equivalent of up to 657.5 billion cubic
TGLO
bas2020 bas2020 4 minutes ago
A typical paid FUDster comment. 👿☠️
NWBO
janice shell janice shell 5 minutes ago
I said "red and blue error message". The Oops error message.
janice shell janice shell 5 minutes ago
Yep. They most definitely are back. But I haven't had int the past hour, so maybe they've been fixed.
noradio noradio 6 minutes ago
Its all even more silly when you take into account how old these guys are...
DBMM
wadegarret wadegarret 6 minutes ago
Anyone here own GERN ? News ah

Looks like the CEO is leaving, but they got EU approval. I think overall good news- we'll see
GERN
NY1972 NY1972 7 minutes ago
819 update at EULAR. Hard to believe they didn't see confirmation data in other 2 patients before adding 10 more pts at 360 mi. cell dose
FATE
janice shell janice shell 8 minutes ago
Oh you won't have any trouble finding lemongrass. Galangal looks like fresh ginger, but it's said to taste quite different. Here ya go:

A Guide To Galangal

https://investorshub.advfn.com/uimage/uploads/2025/3/11/vvtoyimage.jpeg

https://www.tilda.com/blog/
Louie_Louie Louie_Louie 8 minutes ago
Telling you right now, Pulte will be next FHFA head. I bet he's already doing what needs to be done for whatever the first steps will be. Uplist? Seniors cancellation via agreement or consent decree? when it happens it will happen with a few other things GSE related and also a few other things n
FMCC
stealofadeal stealofadeal 9 minutes ago
$MGON Well MGON will likely get sued again and after they do file bankruptcy cause they're flat broke now can barely keep the lights on. SCAM
MGON
TightCoil TightCoil 10 minutes ago
HawkEye Buffett will beat him/her to the punch...by the way,

Why do you think we gained 28 cents
today?
FNMA
RickNagra RickNagra 10 minutes ago
Sounds like to me Pulte will be confirmed Thursday morning.  $8 by Friday.
FNMA
badgerkid badgerkid 11 minutes ago
Theory, agreed. It would seem that the ability to buy large blocks of shares at these lower levels has diminished substantially. Mostly just day trading activity at this point imho. I don't see much reason for more shorting at this level, some covering certainly, but that too isn't in a hurry jus
IOVA
badgerkid badgerkid 15 minutes ago
Sunman, I assume you no longer own any shares of IOVA, being a "smart one" amongst all of us fools?

Do you still own IOVA? I would assume you don't because you suggest that owners of the stock are foolish and ignorant, and you're certainly not foolish nor ignorant, are you?
IOVA

Your Recent History

NASDAQ
FULC
Fulcrum Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads